Investing
Schott Pharma sets IPO price at €27, targets €4.1B market cap
© Reuters.
German pharmaceutical company Schott Pharma is set to make its debut on the Frankfurt Stock Exchange, having set its initial public offering (IPO) price at €27 ($28.36). The pricing, announced on Thursday, falls within the projected range of €24.50 and €28.50.
The valuation puts Schott Pharma’s market capitalization at around €4.1 billion. The firm anticipates gross proceeds of €935 million from the sale of 34.6 million shares. The parent company, Schott, plans to retain a significant majority stake of at least 77% following the IPO.
In a noteworthy development, Qatar Holding has secured a 4.9% stake in Schott Pharma through an investment of €200 million. The IPO and subsequent listing on the Frankfurt Stock Exchange represent a significant milestone for Schott Pharma in its growth trajectory. It will be closely watched by investors and industry stakeholders alike as it unfolds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
-
Personal Finance4 days ago
Social Security cost-of-living adjustment will be 2.5% in 2025, less than prior year
-
Investing6 days ago
U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 1.37% By Investing.com
-
Investing6 days ago
AI Pioneers Win $1.06 Million, 2024 Nobel Prize in Physics
-
Make Money6 days ago
The Top Employers and Opportunities for Part-Time Remote Jobs
-
Passive Income6 days ago
How to Build a Workplace Culture Centered on Love, Abundance and Purpose
-
Investing5 days ago
JPMorgan Chase CEO Jamie Dimon: AI Will Take Over Some Jobs
-
Side Hustles4 days ago
Oldest Children Like Bezos, Musk Have 2 Leadership Qualities
-
Passive Income4 days ago
4 Marketing Triggers to Set Up Now to Supercharge Your New Year